feed,title,long_url,short_url
ðŸ’°Barrons,Hims & Hers is in the FDAâ€™s Crosshairs. Itâ€™s a Risk to the Telehealth Stock,https://barrons.com/articles/hims-hers-fda-stock-price-5b3de800?mod=RTA,
